These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25361945)

  • 1. Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective.
    Andritsos LA; Dunavin N; Lozanski G; Jones JA; Blachly JS; Lucas DM; Byrd JC; Kraut E; Grever MR
    Haematologica; 2015 Jan; 100(1):e18-20. PubMed ID: 25361945
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairy cell leukemia.
    Dearden C
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):163-5. PubMed ID: 26614893
    [No Abstract]   [Full Text] [Related]  

  • 4. Pentostatin in the treatment of hairy-cell leukemia.
    Grever MR; Doan CA; Kraut EH
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):91-9. PubMed ID: 12670468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
    Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
    J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
    Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
    Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
    Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic improvement after flavopiridol treatment of pentostatin and rituximab refractory hairy cell leukemia.
    Jones JA; Kraut EH; Deam D; Byrd JC; Grever MR
    Leuk Lymphoma; 2012 Mar; 53(3):490-1. PubMed ID: 22165992
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
    Else M; Dearden CE; Catovsky D
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
    Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.
    Flinn IW; Kopecky KJ; Foucar MK; Head D; Bennett JM; Hutchison R; Corbett W; Cassileth P; Habermann T; Golomb H; Rai K; Eisenhauer E; Appelbaum F; Cheson B; Grever MR
    Blood; 2000 Nov; 96(9):2981-6. PubMed ID: 11049974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia.
    Lichtman SM; Wasil T; Ahmad M; Brody J
    Leuk Lymphoma; 1998 Jan; 28(3-4):423-7. PubMed ID: 9517515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin.
    Ng JP; Nolan B; Chan-Lam D; Coup AJ; McKenna D
    Hematology; 2002 Aug; 7(4):259-62. PubMed ID: 14972788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
    Seymour JF; Talpaz M; Kurzrock R
    Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.
    Saven A; Burian C; Koziol JA; Piro LD
    Blood; 1998 Sep; 92(6):1918-26. PubMed ID: 9731048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentostatin induces durable remissions in hairy cell leukemia.
    Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up studies in hairy cell leukemia.
    Grever MR; Zinzani PL
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():23-6. PubMed ID: 19814694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.